This study aims to evaluate the effects of Munziq and Mushil therapy on asthma patients with abnormal savda syndrome. During March 2012 to October 2013, 75 asthma patients with abnormal savda syndrome from Rrespiratory Department of the First Affiliated Hospital of Xinjiang Medical University were randomly assigned to the treatment group (n=38) and control group (n=37). The control group received budesonide and formoterol fumarate powder for inhalation (symbicort turbuhaler), and the treatment group received traditional Uyghur medicine combined with those for the control group; The course of treatment was one month. The day and night clinical symptoms of asthma, ACT grade and asthma quality of life questionnaire (AQLQ) grade were observed and compared. In one month, asthma was well controlled in 91.9% of patients in the control group and 94.8% of patients in the treatment group, but the difference was not significant statistically (P>0.05). Compared to the baseline, day and night symptom controlled scores and ACT scores increased in both groups, but not statistically different in one month (P>0.05). The AQLQ grades of both groups were improved after one month treatment compared to the baseline, and the mean difference was significantly different between the two groups (P<0.05). Health related quality of life subscale such as exercise endurance, mentality status, reaction to stimulation and care to own health were significantly higher in the treatment group than in the control group. Traditional Uyghur medicine combined with western medicine showed similar effects in improving in ACT grades and AQLQ grades of asthma patients when compared to use of western medicine alone. However, use of traditional Uyghur medicine can improve health related quality of life of asthma patients when combined with western medicine, which was its advantage.
AWUTI Maliyegu, MIJITI Peierdun, AIHEMAITI Xiamixinuer, ABUDULA Abulizi, UPUR Halmurat
. Observation of effects of munziq and mushil therapy on asthma patients with abnormal savda syndrome[J]. Science & Technology Review, 2015
, 33(22)
: 93
-96
.
DOI: 10.3981/j.issn.1000-7857.2015.22.016
[1] 李文昌, 朱颖蓉, 廖文彦. 类固醇激素治疗支气管哮喘临床疗效分析[J]. 医学信息, 2008, 4(8): 139-142. Li Wenchang, Zhu Yingrong, Liao Wenyan. Analysis of effectiveness of Steroid hormone therapy on bronchial asthma[J]. Journal of Medical Information, 2008, 4(8): 139-142.
[2] 哈木拉提·吾甫尔, 杨剑, 李风森, 等. 西医重度哮喘、中医虚哮型哮喘 和维医异常黑胆质哮喘的交互性研究[J]. 科技导报, 2008, 26(6): 50- 52. Upur Halmurat, Yang Jian, Li Fengsen, et al. Relationship between severe asthma in western medicine, virtual roar asthma in chinese medicine, and abnormal savda in Uygur medicine[J]. Science & Technology Review, 2008, 26(6): 50-52.
[3] 中华医学会呼吸病学分会哮喘学组. 支气管哮喘防治指南[J]. 中华内 科杂志, 2003, 42(11): 817-822. Chinese medical association of respiratory disease branch asthma study group. Guidelines on prevention and treatment of bronchial asthma[J]. Chinese Journal of Internal Medicine, 2003, 42(11): 817-822.
[4] 阿布力米提·于素普. 维吾尔医诊断学[M]. 乌鲁木齐: 新疆科学技术 出版社, 1991: 181-184. Yusupu Abulimiti. Diagnosis of Uighur medicine[M]. Urumqi: Xinjiang Science and Technology Publishing House, 1991: 181-184.
[5] 哈木拉提·吾甫尔. 气质体液论及其现代研究[M]. 乌鲁木齐: 新疆科 技卫生出版社, 2003. Upur Hamulati. Temper and humoral theory and its modern research[M]. Urumqi: Xinjiang Technology and Hygiene Publishing House, 2003.
[6] 哈木拉提·吾甫尔, 阿不都热依木·玉素甫, 努尔买买提·艾买提. 维吾 尔医异常黑胆质新论[M]. 乌鲁木齐: 新疆人民出版社, 2009. Upur Hamulati, Abudureyimu Yusufu Nuermaimaiti Aimaiti. New conception of the theory of abnormal savda in traditional Uyghur medicine[M]. Urumqi: Xinjiang People Publishing House, 2009.
[7] 赵德育, 季纯珍, 秦铭, 等. 哮喘控制简易方案在儿科的临床应用[J]. 江苏临床医学杂志, 2002, 6(4): 317-321. Zhao Deyu, Ji Chunzhen, Qin Ming, et al. Application of astham control easy plan on pediatrics[J]. Journal of Jiangsu Clinical Medicine, 2002, 6 (4): 317-321.
[8] 李凡, 蔡映月云, 王蓓玲, 等. 5分制成人哮喘生存质量评分表的检验[J]. 现代康复, 2001, 5(12):7-9. Li Fan, Cai Yingyueyun, Wang Beiling, et al. Testing of 5-score adult asthma quality of life[J]. Journal of Modern Treatment, 2001, 5(12): 7-9.
[9] Aikemu A, Umar A, Yusup A, et al. Immunomodulatory and antitumour effects of abnormal savda munziq on S180 tumour- bearing mice[J]. BMC Complementary and Alternative Medicine, 2012, 12: 157-163.
[10] 张静波, 计焱焱. 支气管哮喘患者抗炎治疗前后生存质量的变化[M]. 中国临床药理学与治疗学, 2000, 5(3): 231-234. Zhang Jingbo, Ji Yanyan. Changes of quality of life of asthma patients before and after anti-biotic treatment[J]. Chinese Journal of Clinical Pharmacologic Therapy, 2000, 5(3): 231-234.
[11] Bonala S B, Pina D, Bernard A, et al. Asthma severity, psychiatric morbidity, and quality of life: Correlation with inhaled corticosteroid dose[J]. Journal of Asthma, 2003, 40(6): 691-699.
[12] Lewis L D, Cochrane G M. Psychosis in a child inhaling budesonide[J]. Lancet, 1983, 2(8350): 634.
[13] Goldstein E T, Preskorn S H. Mania triggered by a steroid nasal spray in a patient with stable bipolar disorder[J]. American Journal of Psychiatry, 1989, 146(8):1076-1077.
[14] van Gaalen J L, Bakker M J, van Bodegom-Vos L, et al. Implementation strategies of internet-based asthma self-management support in usual care. Study protocol for the IMPASSE cluster randomized trial[J]. Implementation Science, 2012, 7: 113-123.
